Cabaletta Bio (CABA) Enterprise Value (2019 - 2026)

Cabaletta Bio's Enterprise Value history runs 8 years deep, the most recent figure standing at -$184.2 million for Q4 2025.

• In Q4 2025, Enterprise Value fell 12.35% year-over-year to -$184.2 million; the TTM figure through Dec 2025 stood at -$184.2 million (down 12.35% YoY), while the FY2025 annual figure was -$184.2 million, down 12.35% from the prior year.
• Enterprise Value for Q4 2025 stood at -$184.2 million, down from -$159.9 million in the prior quarter.
• The five-year high for Enterprise Value was -$93.8 million in Q1 2023, with the low at -$272.4 million in Q1 2024.
• The 5-year median for Enterprise Value is -$145.9 million (2025), against an average of -$161.5 million.
• The sharpest annual moves came in 2024 and 2025: Enterprise Value slumped 190.26% in 2024, then jumped 51.6% in 2025.
• Cabaletta Bio's Enterprise Value stood at -$122.2 million in 2021, then climbed by 12.83% to -$106.5 million in 2022, then sank by 126.42% to -$241.2 million in 2023, then soared by 32.04% to -$164.0 million in 2024, then declined by 12.35% to -$184.2 million in 2025.
• Business Quant data shows CABA's Enterprise Value at -$184.2 million in Q4 2025, -$159.9 million in Q3 2025, and -$243.8 million in Q2 2025.